FBLDFragment Based Lead Discovery (Conference)
References in periodicals archive ?
Carmot will use the FBLD technology, called "Chemotype Evolution," for identifying promising drug candidates in a broad range of therapeutic areas, including inflammatory, metabolic, and neurodegenerative diseases.
launched the AP-3000 label-free surface plasmon resonance (SPR) detection system for fragment-based lead discovery (FBLD), a drug discovery strategy for developing drugs by identifying small (150-300 Daltons) chemical fragments that bind only weakly to biological targets.
Objective: The promise of more efficient lead discovery is fuelling the enthusiasm for fragment-based lead discovery (FBLD).